Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Perceptive Life Sciences Master Fund Ltd
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   2,270,404    

Indirect Shares

   99,979,160      
Direct Value   $1,366,783    

Indirect Value

   $321,937,176      
Total Shares   102,249,564      
Total Value   $323,303,959      


VBI Vaccines Inc $1,366,783 VBI Vaccines Inc $1,366,783
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Penwest Pharmaceuticals Co PPCO 10% Owner 2008-09-29 0 2008-10-24 6,422,846    Premium*  
            XTL Biopharmaceuticals Ltd XTLBY 10% Owner 2008-11-19 0 2008-11-19 20,580,260    Premium*  
            Optimer Pharmaceuticals Inc OPTR 10% Owner 2008-07-02 0 2008-07-02 113,442    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-07-01 26,666,667    Premium*  
            Aegerion Pharmaceuticals, Inc. AEGR 10% Owner 2012-12-04 0 2013-09-05 2,823,426    Premium*  
            Acelrx Pharmaceuticals Inc ACRX 10% Owner 2013-07-23 0 2016-09-29 5,386,410    Premium*  
            Amicus Therapeutics Inc FOLD 10% Owner 2014-06-30 0 2016-12-30 16,293,847    Premium*  
            VBI Vaccines Inc VBIV 10% Owner 2014-07-25 2,270,404 2016-12-06 6,213,314    Premium*  
            Aldeyra Therapeutics, Inc. ALDX 10% Owner 2015-10-20 0 2017-02-14 2,589,451    Premium*  
            Aravive Inc ARAV 10% Owner 2016-12-29 0 2017-02-13 4,228,563    Premium*  
            Corium International, Inc. CORI 10% Owner 2017-05-25 0 2017-05-25 5,546,129    Premium*  
            Athira Pharma, Inc. ATHA 10% Owner 0 2020-09-22 3,114,805    Premium*  
* Premium Members only  

Records found :    62         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2011-07-01 3 IO $0.00 $0 I/I 0 26,666,667 -
VBIV VBI Vaccines Inc 10% Owner   –       –       •   2014-07-25 3 IO $0.00 $0 D/D 0 2,270,404 -
CORI Corium International, Inc... 10% Owner   –       –       •   2017-05-19 3 IO $0.00 $0 I/I 0 3,643,729 -
ATHA Athira Pharma, Inc. 10% Owner   –       –       •   2020-09-17 3 IO $0.00 $0 I/I 0 411,196 -
ATHA Athira Pharma, Inc. 10% Owner   –       –       •   2020-09-22 4 A $0.00 $0 I/I 1,644,785 2,055,981 0 -
XTLBY XTL Biopharmaceuticals Lt... 10% Owner   –       –       •   2008-11-18 4 S $0.14 $4,339,608 I/I (30,450,370) 0 0 -
XTLBY XTL Biopharmaceuticals Lt... 10% Owner   –       –       •   2008-11-19 4 S $0.15 $1,466,880 I/I (9,600,000) 20,580,260 0 -
VBIV VBI Vaccines Inc 10% Owner   –       –       •   2015-08-14 4 B $2.08 $1,352,000 I/I 650,000 3,260,356 1.5 -
VBIV VBI Vaccines Inc 10% Owner   –       –       •   2016-12-06 4 B $3.05 $10,321,063 I/I 3,383,955 6,213,314 1.5 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2014-06-30 4 B $3.50 $14,000,000 I/I 4,000,000 12,339,444 1.5 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2016-09-15 4 S $3.63 $1,452,811 I/I (392,850) 5,602,910 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2016-09-29 4 S $3.88 $377,117 I/I (97,200) 5,386,410 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2016-09-28 4 S $3.96 $472,380 I/I (119,300) 5,483,610 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2015-09-09 4 S $4.18 $1,294,777 I/I (310,000) 6,264,060 0 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2015-11-06 4 S $4.47 $76,365 I/I (17,100) 6,171,960 0 -
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2017-02-14 4 B $4.50 $4,018,613 I/I 893,025 2,589,451 1.5 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2016-12-22 4 B $4.51 $854,835 I/I 189,500 16,066,447 1.5 -
ACRX Acelrx Pharmaceuticals In... 10% Owner   –       –       •   2015-11-05 4 S $4.62 $346,260 I/I (75,000) 6,189,060 0 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2016-12-23 4 B $4.72 $410,050 I/I 85,275 16,151,722 1.5 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2016-12-29 4 B $4.85 $459,917 I/I 94,750 16,293,847 1.5 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2016-12-28 4 B $4.91 $232,706 I/I 47,375 16,199,097 1.5 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2016-12-30 4 B $4.96 $470,055 I/I 94,750 16,293,847 1.5 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2008-06-20 4/A B $5.00 $17,500 I/I 3,500 274,362 1.5 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2008-06-23 4/A B $5.00 $137,500 I/I 27,500 6,415,046 1.5 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2008-09-29 4 B $5.00 $22,500 I/I 4,500 6,419,546 1.5 -
  62  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us